MONROVIA – In a ruling with far-reaching implications for governance and the rule of law, the Supreme Court of Liberia has ordered the immediate reinstatement of Dougbeh Christopher Nyan as Director General of the National Public Health Institute of Liberia, declaring that his removal by the Executive Branch under President Joseph Nyuma Boakai was unconstitutional and in violation of statutory due-process protections.
The ruling, delivered on February 16, 2026, by Chambers Justice Jamesetta Howard-Wolokolie, follows arguments heard on January 15, 2026, and emphasizes the inviolability of fixed-term tenure for public officials. The Court found that Dr. Nyan’s dismissal lacked procedural justification and violated both statutory and constitutional safeguards.
Central to the Court’s reasoning is the sanctity of contract. The justices underscored that tenure holders enter into a valid contractual relationship with the Republic of Liberia, which must be honored unless there is proven cause for removal. “Based on the letter of the statute, it is implied that the Commissioners entered into a valid contract with the Republic of Liberia to serve in their respective capacities for the period indicated therein,” the Court stated.
The ruling further stressed that the Executive Branch cannot unilaterally terminate officials without lawful procedure. “Where an official is removed from office before the expiration of his tenure for reasons other than proven cause, as the instant case shows, the State remains liable for the benefits and emoluments that would have accrued for the remainder of the tenure,” the judgment clarified.
Dr. Nyan, a globally acclaimed biomedical scientist, filed a Petition for a Writ of Prohibition on October 23, 2025, challenging his dismissal on October 15, 2025, following a Board resolution that alleged “gross inefficiency” but provided no supporting evidence. His legal team, led by Cllr. Tiawan Saye Gongloe and Cllr. Kabineh Ja’neh of Gongloe & Associates Law Firm, argued that the dismissal was arbitrary, politically motivated, and in clear contravention of the NPHIL Act of 2016.
During oral arguments, government lawyers reportedly failed to submit briefs and relied primarily on a resolution from the NPHIL Board, supported by affidavits from Health Minister Louise Kpoto and Board Chair Stephen Kennedy. The affidavits, according to court observers, focused heavily on administrative grievances but did not present evidence of a formal investigation or documented findings.
Government attorneys further argued that the President possesses authority to terminate appointed officials “at will.” However, the Court found no legal basis supporting at-will termination for a position protected by a fixed statutory tenure. Under questioning, state lawyers reportedly failed to produce investigative reports or documentation to justify the removal.
In contrast, Dr. Nyan’s legal team cited precedent cases, including Yealue et al. v. Executive Branch, reinforcing the principle that tenure-protected officials cannot be dismissed without adherence to due process. The Supreme Court agreed, affirming that prohibition was warranted to prevent an unlawful exercise of executive power.
The ruling marks a significant affirmation of judicial independence and the doctrine of separation of powers. Legal analysts say the decision strengthens institutional safeguards against arbitrary removals and reinforces the authority of statutory protections granted by the Legislature.
Dr. Nyan’s reinstatement also returns to leadership a public health expert widely credited with strengthening NPHIL’s administrative and technical capacity since assuming office on August 19, 2024. Under his leadership, Liberia mounted coordinated responses to Mpox, Lassa fever, and measles outbreaks, drawing praise from regional health partners.
Notably, NPHIL earned designation from the Africa CDC as an Africa Regional Center of Excellence for National Public Health Institute Development, reflecting what independent observers described as “substantial progress” in institutional reform and disease surveillance systems.
These achievements were reportedly supported by independent reports from the General Auditing Agency and NPHIL’s 2025 Annual Reports, which contradicted claims of “gross inefficiency” cited in the Board’s resolution recommending his removal.
Beyond his administrative leadership, Dr. Nyan is internationally recognized for his contributions to biomedical science, infectious disease diagnostics, and innovation. He has been honored as an Africa CDC Champion of Biomedical Science and Research for the West African Region and was awarded the 2025 African Genius Award for scientific excellence.
